Peyrin-Biroulet L - Search Results

1

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials.

Almradi A, Ma C, D'Haens GR, Sandborn WJ, Parker CE, Guizzetti L, Borralho Nunes P, De Hertogh G, Feakins RM, Khanna R, Lauwers GY, Mookhoek A, Pai RK, Peyrin-Biroulet L, Riddell R, Rosty C, Schaeffer DF, Valasek MA, Singh S, Crowley E, Feagan BG, Jairath V, Pai RK. Almradi A, et al. Aliment Pharmacol Ther. 2021 Apr;53(7):784-793. doi: 10.1111/apt.16248. Epub 2021 Jan 7. Aliment Pharmacol Ther. 2021. PMID: 33410551

2

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.

Peyrin-Biroulet L, Deltenre P, de Suray N, Branche J, Sandborn WJ, Colombel JF. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2008 Jun;6(6):644-53. doi: 10.1016/j.cgh.2008.03.014. Clin Gastroenterol Hepatol. 2008. PMID: 18550004

3

Crohn's disease: beyond antagonists of tumour necrosis factor.

Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF. Peyrin-Biroulet L, et al. Lancet. 2008 Jul 5;372(9632):67-81. doi: 10.1016/S0140-6736(08)60995-2. Lancet. 2008. PMID: 18603161 Review.

4

Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease.

Peyrin-Biroulet L, Colombel JF, Sandborn WJ. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2009 Oct;7(10):1139. doi: 10.1016/j.cgh.2009.05.012. Epub 2009 May 22. Clin Gastroenterol Hepatol. 2009. PMID: 19465159 No abstract available.

5

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.

Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF. Peyrin-Biroulet L, et al. Am J Gastroenterol. 2009 Aug;104(8):2089-96. doi: 10.1038/ajg.2009.301. Epub 2009 Jun 30. Am J Gastroenterol. 2009. PMID: 19568226 Review.

6

The natural history of adult Crohn's disease in population-based cohorts.

Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Peyrin-Biroulet L, et al. Am J Gastroenterol. 2010 Feb;105(2):289-97. doi: 10.1038/ajg.2009.579. Epub 2009 Oct 27. Am J Gastroenterol. 2010. PMID: 19861953 Review.

7

Early Crohn disease: a proposed definition for use in disease-modification trials.

Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Peyrin-Biroulet L, et al. Gut. 2010 Feb;59(2):141-7. doi: 10.1136/gut.2009.187120. Gut. 2010. PMID: 20176633 No abstract available.

8

Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.

Oussalah A, Chevaux JB, Fay R, Sandborn WJ, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Am J Gastroenterol. 2010 May;105(5):1142-9. doi: 10.1038/ajg.2010.158. Epub 2010 Apr 13. Am J Gastroenterol. 2010. PMID: 20389296

9

Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.

Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Peyrin-Biroulet L, et al. Inflamm Bowel Dis. 2011 Jan;17(1):471-8. doi: 10.1002/ibd.21417. Epub 2010 Aug 19. Inflamm Bowel Dis. 2011. PMID: 20725943 Review.

10

Perianal Crohn's disease findings other than fistulas in a population-based cohort.

Peyrin-Biroulet L, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Peyrin-Biroulet L, et al. Inflamm Bowel Dis. 2012 Jan;18(1):43-8. doi: 10.1002/ibd.21674. Epub 2011 Feb 23. Inflamm Bowel Dis. 2012. PMID: 21351216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,039 results

Search Page